Barry Wolfenson, VP - Marketing & Business Development at DERMA SCIENCES, INC. (DSCI), bought 35,000 shares at $0.70 ($25K) on 2007-12-07, disclosed to the SEC on 2007-12-11.
Open-market purchase of $24k DSCI by VP - Marketing & Business Development. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Clearly above the average filing.
| Filing → |
| DSCI | BUY | 2009-03-18 | $10K | — | Filing → |